Publicaciones en colaboración con investigadores/as de Hospital de Cruces (370)

2024

  1. Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study

    Clinical Microbiology and Infection, Vol. 30, Núm. 8, pp. 1035-1041

  2. Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study

    Transplantation

  3. Clinical Predictors of Mood Disorders and Prevalence of Neuropsychiatric Symptoms in Patients with Systemic Lupus Erythematosus

    Journal of Clinical Medicine, Vol. 13, Núm. 18

  4. Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 10, pp. 2011-2022

  5. Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

    Rheumatology (United Kingdom), Vol. 63, Núm. 3, pp. 772-779

  6. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease

    BMJ Open, Vol. 14, Núm. 4

  7. Description of reinfection of joint prosthesis after 2-stage replacement (infection of the 2nd stage prosthesis): A multicenter study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 7, pp. 354-360

  8. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

  9. Elucidating the mechanisms and efficacy of antimalarial drugs in systemic lupus erythematosus

    Expert Opinion on Pharmacotherapy

  10. Epidemiology and Risk Factors of Mycotic Aneurysm in Patients With Infective Endocarditis and the Impact of its Rupture in Outcomes. Analysis of a National Prospective Cohort

    Open Forum Infectious Diseases, Vol. 11, Núm. 3

  11. Impact of antibiotic prophylaxis in second-stage surgery in joint prosthesis infection treated with two-stage exchange. A multicenter case–control study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 7, pp. 1319-1328

  12. Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

    Arthritis Care and Research, Vol. 76, Núm. 8, pp. 1132-1138

  13. Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: Results from the prospective, multicentre cohort PROBAC

    International Journal of Infectious Diseases, Vol. 145

  14. Not everything aggressive is tumoral: Bartonella henselae osteomyelitis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 457-458

  15. Obstetric antiphospholipid syndrome

    Medicina Clinica, Vol. 163, pp. S14-S21

  16. Proposing a workload indicator for hospital at home patients in Osakidetza - Basque Public Health Service

    Journal of Healthcare Quality Research, Vol. 39, Núm. 2, pp. 80-88

  17. Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the Rheumatic Diseases

  18. Sustainability assessment of a quality improvement initiative on the management of bronchiolitis

    Archives of Disease in Childhood

  19. Thrombotic antiphospholipid syndrome: From guidelines to clinical management

    Medicina Clinica, Vol. 163, pp. S22-S30

  20. Use of Glucocorticoids in SLE: A Clinical Approach

    Mediterranean Journal of Rheumatology, Vol. 35, pp. 342-353